Below are the financial statements of Chugai Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of JPY | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Non-current assets | — | — |
| Property, plant and equipment | 433.13a | 409.94a |
| Right-of-use assets | 8.43a | 10.76a |
| Intangible assets | 17.87a | 19.86a |
| Deferred tax assets | 69.84a | 64.47a |
| Defined benefit plan assets | 13.98a | 7.48a |
| Other non-current assets | 59.09a | 53.61a |
| Total non-current assets | 602.33a | 566.12a |
| Current assets | — | — |
| Inventories | 240.07a | 273.48a |
| Accounts receivable | 334.26a | 318.89a |
| Current income tax assets | 0.9a | 1.46a |
| Marketable securities | 456.14a | 280.31a |
| Cash and cash equivalents | 540.2a | 458.67a |
| Other current assets | 34.48a | 33.62a |
| Total current assets | 1,606.04a | 1,366.43a |
| Total assets | 2,208.37a | 1,932.55a |
| Liabilities | — | — |
| Non-current liabilities | — | — |
| Deferred tax liabilities | -5.08a | -5.79a |
| Defined benefit plan liabilities | -3.94a | -3.15a |
| Long-term provisions | -2.19a | -2.59a |
| Other non-current liabilities | -5.32a | -7.22a |
| Total non-current liabilities | -16.52a | -18.75a |
| Current liabilities | — | — |
| Current income tax liabilities | -108.73a | -40.8a |
| Short-term provisions | -2.97a | -3.44a |
| Accounts payable | -65.35a | -112.47a |
| Other current liabilities | -113.3a | -131.51a |
| Total current liabilities | -290.36a | -288.22a |
| Total liabilities | -306.87a | -306.97a |
| Total net assets | 1,901.5a | 1,625.58a |
| Equity | — | — |
| Capital and reserves attributable to Chugai shareholders | 1,901.5a | 1,625.58a |
| Total equity | 1,901.5a | 1,625.58a |
| Total liabilities and equity | 2,208.37a | 1,932.55a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.